Acorda Therapeutics, Inc. Future Amortization Expense, Year Two (Deprecated 2012-01-31)
Acorda Therapeutics, Inc. reported Future Amortization Expense, Year Two (Deprecated 2012-01-31) of $1.14 million for the 12-month period ending 2011-12-31, per its 10-K filed 2012-02-28.
Discontinued › Expense Statement › Operating Expenses
us-gaap:FutureAmortizationExpenseYearTwo · last filed 2012-02-28
- Acorda Therapeutics, Inc. future amortization expense, year two (deprecated 2012-01-31) for fiscal 2011 was $1.14M.
| Period end | Future Amortization Expense, Year Two (Deprecated 2012-01-31) 12 month | Future Amortization Expense, Year Two (Deprecated 2012-01-31) 12 month as first filed |
|---|---|---|
| 2011-12-31 | $1.14M 10-K · filed 2012-02-28 | |
| 2010-12-31 | $1.39M 10-Q · filed 2011-11-07 | $2.59M 10-Q · filed 2011-08-08 |